Evidence map›Paper›PMID 18495786›Full record

ReviewJournal of leukocyte biology2008

Cytokines, leptin, and stress-induced thymic atrophy.

Amanda L Gruver, Gregory D Sempowski

Open access · greenAbstract readReview
In one paragraph

Review in Journal of leukocyte biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 233 citations in OpenAlex.

  1. Trial
  2. Risk Factors for Secondary Immunodeficiency in the Aged.The journal of allergy and clinical immunology. In practice · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Cocaine abuse and its impact on the thymus and spleen.Histology and histopathology · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Amanda L GruverDepartment of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
Gregory D Sempowski
Duke Medical Center · US

Funding

Regional Biocontainment Laboratory (RBL)UC6AI058607 · NIAID · DUKE UNIVERSITY · PI WILLIAMS, R SANDERS · 2003 to 2005
$16.3M
Duke University Center for Translational ResearchP30AI051445 · NIAID · DUKE UNIVERSITY · PI FROTHINGHAM, RICHARD · 2002 to 2006
$8.1M
Mechanisms of Age Induced Thymic AtrophyR01AG025150 · NIA · DUKE UNIVERSITY · PI SEMPOWSKI, GREGORY D · 2005 to 2009
$1.5M
NIAID NIH HHS AI51445NIAID NIH HHS AI58607NIAID NIH HHS P30 AI051445NIAID NIH HHS UC6 AI058607NIA NIH HHS AG25150NIA NIH HHS R01 AG025150
6 · The paper itself

Abstract

Thymopoiesis is essential for development and maintenance of a robust and healthy immune system. Acute thymic atrophy is a complication of many infections, environmental stressors, clinical preparative regimens, and cancer treatments used today. This undesirable sequela can decrease host ability to reconstitute the peripheral T cell repertoire and respond to new antigens. Currently, there are no treatments available to protect against acute thymic atrophy or accelerate recovery, thus leaving the immune system compromised during acute stress events. Several useful murine models are available for mechanistic studies of acute thymic atrophy, including a sepsis model of endotoxin-induced thymic involution. We have identified the IL-6 cytokine gene family members (i.e., leukemia inhibitory factor, IL-6, and oncostatin M) as thymosuppressive agents by the observation that they can acutely involute the thymus when injected into a young, healthy mouse. We have gone on to explore the role of thymosuppressive cytokines and specifically defined a corticosteroid-dependent mechanism of action for the leukemia inhibitory factor in acute thymic atrophy. We also have identified leptin as a novel, thymostimulatory agent that can protect against endotoxin-induced acute thymic atrophy. This review will highlight mechanisms of stress-induced thymic involution and focus on thymosuppressive agents involved in atrophy induction and thymostimulatory agents that may be exploited for therapeutic use.

Indexed as

AnimalsAtrophyCytokinesHumansLeptinLife ExpectancyLipopolysaccharidesModels, AnimalSatiety ResponseStress, PhysiologicalThymus GlandT-LymphocytesCytokinesLeptinLipopolysaccharides

Identifiers

PMID18495786
PMCPMC2538595
OpenAlexW2126143610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.